BioPlus Acquisition Corp.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
1/10
|
1183.3 | 25.96 | 4457.72% | 1183.3 | 0% |
| P/S |
|
0 | 4.82 | -100% |
|
|
| P/BV |
|
27.4 | 0.8945 | 2962.96% |
|
|
| P/FCF |
|
0 | 32.94 | -100% |
|
|
| Ev/Ebitda |
|
-5220.56 | 17.63 | -29704.95% |
|
|
| Ev/S |
|
0 | 4.85 | -100% |
|
|
| Ev/FCF |
|
-8842.26 | 50.47 | -17618.94% |
|
|
| E/P |
|
0 | 0.1269 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 22.3 | -100% | -11.04 | -100% |
| ROE |
|
2.33 | 6.09 | -61.79% |
|
|
| ROA |
|
2.18 | 5.76 | -62.22% |
|
|
| ROIC |
|
0 | 5.05 | -100% |
|
|
| ROS |
|
0 | 22.96 | -100% |
|
|
| ROCE |
|
0 | -8.3 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-4.17 | -8.85 | -52.93% | -4.54 | -8.28% |
| Nеt Debt/Ebitda |
|
-4.08 | 19.27 | -121.2% |
|
|
| Debt/Ratio |
|
0.021 | 0.2093 | -89.97% |
|
|
| Debt/Equity |
|
0 | 14.67 | -100% |
|
|
| Debt/Net Income |
|
0.9615 | 4.86 | -80.21% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 1.71 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 2.96 | -100% | ||
| DSI |
|
0 | 0.7821 | -100% |
|
|
| Average dividend growth |
|
0 | 1.55 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 2 | -100% |
|
|
| Average percentage for payments |
|
0 | 48.49 | -100% |
|
|
| Difference from average difference in sector |
|
-1.71 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-27.96 | 9056.96 | -100.31% | ||
| Growth impulse Ebitda in 5 years |
|
-99.65 | 33.7 | -395.7% | ||
| Growth impulse Net Income in 5 years |
|
-115.01 | 27.15 | -523.61% | ||
| Growth impulse FCF in 5 years |
|
-99.09 | 51.36 | -292.93% | ||
| Growth impulse EPS in 5 years |
|
-132.2 | 246.95 | -153.53% |
IP Score
2.18/10
